- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Zymogenetics Inc.
Headquarters: Seattle, WA, United States
Website: N/A
Year Founded: 1981
Status: Acquired
BioCentury | Apr 10, 2023
Product Development
Williams, Meininger tasked with validating Sana’s platforms in the clinic
The ex-Codiak and Vertex execs bring translational and clinical expertise in new modalities
BioCentury | Jan 20, 2021
Product Development
Trucode reboots as Vera with Abingworth-led $80M series C, disease-modifying therapy for orphan kidney disease
Sixteen months after it emerged from stealth, Trucode has moved on from gene editing and relaunched as Vera with an Abingworth-led $80 million series C round to build an in-licensed
BioCentury | Jun 22, 2020
Emerging Company Profile
Prosit Sole: chimeric proteins for rare disease
Prosit Sole aims to improve known therapeutic proteins, cytokine drugs through chimeras
BioCentury | Jan 6, 2014
Clinical News
Tretten recombinant coagulation Factor XIII A-subunit regulatory update
BioCentury | Dec 24, 2013
Company News
FDA approves Novo product for congenital Factor XIII deficiency
Items per page:
1 - 10 of 317